Elham Asgari1, Wuding Zhou, Steven Sacks. 1. MRC Centre for Transplantation, King's College London, Guy's Hospital, Great Maze Pond, London, UK.
Abstract
PURPOSE OF REVIEW: The aim of this review is to bring to attention the most recent advances made in understanding the role of complement components in both innate and adaptive immune responses in solid organ transplantation with emphasis on the kidney. RECENT FINDINGS: Alongside recent findings related to the role of anaphylatoxins in modulating adaptive immune responses, there has been a genomic study to assess the expression of inflammatory markers in kidney transplantation, showing significant involvement of some complement molecules in predicting graft function. Modulators of complement pathway activity such as decay accelerating factor (CD55) and CD59 have also been shown to have a role in graft rejection. Potential new therapeutic targets related to complement proteins are being investigated. SUMMARY: The mechanism of rejection in solid organ transplantation is influenced by the initial inflammatory response and subsequent adaptive allo-immune response, both of which have been shown to be affected by various complement components. Due to limitations of existing treatments, new approaches are needed to better control these responses to improve graft survival. Built on an expanding knowledge of complement involvement, targeted blocking of the effector complement molecules and modulating the expression of complement inhibitors has suggested potentially useful approaches for reducing the effect of inflammatory damage from cold ischaemia as well as reducing the activation of the adaptive immune system related to complement.
PURPOSE OF REVIEW: The aim of this review is to bring to attention the most recent advances made in understanding the role of complement components in both innate and adaptive immune responses in solid organ transplantation with emphasis on the kidney. RECENT FINDINGS: Alongside recent findings related to the role of anaphylatoxins in modulating adaptive immune responses, there has been a genomic study to assess the expression of inflammatory markers in kidney transplantation, showing significant involvement of some complement molecules in predicting graft function. Modulators of complement pathway activity such as decay accelerating factor (CD55) and CD59 have also been shown to have a role in graft rejection. Potential new therapeutic targets related to complement proteins are being investigated. SUMMARY: The mechanism of rejection in solid organ transplantation is influenced by the initial inflammatory response and subsequent adaptive allo-immune response, both of which have been shown to be affected by various complement components. Due to limitations of existing treatments, new approaches are needed to better control these responses to improve graft survival. Built on an expanding knowledge of complement involvement, targeted blocking of the effector complement molecules and modulating the expression of complement inhibitors has suggested potentially useful approaches for reducing the effect of inflammatory damage from cold ischaemia as well as reducing the activation of the adaptive immune system related to complement.
Authors: J E Locke; C M Magro; A L Singer; D L Segev; M Haas; A T Hillel; K E King; E Kraus; L M Lees; J K Melancon; Z A Stewart; D S Warren; A A Zachary; R A Montgomery Journal: Am J Transplant Date: 2008-10-31 Impact factor: 8.086
Authors: Sergey V Brodsky; Gyongyi M Nadasdy; Ronald Pelletier; Anjali Satoskar; Daniel J Birmingham; Gregg A Hadley; Khaled Obeidat; Tibor Nadasdy Journal: Transplantation Date: 2009-08-27 Impact factor: 4.939
Authors: R P Rother; J Arp; J Jiang; W Ge; S J Faas; W Liu; D R Gies; A M Jevnikar; B Garcia; H Wang Journal: Am J Transplant Date: 2008-04-29 Impact factor: 8.086
Authors: Juan S Danobeitia; Tiffany J Zens; Peter J Chlebeck; Laura J Zitur; Jose A Reyes; Michael J Eerhart; Jennifer Coonen; Saverio Capuano; Anthony M D'Alessandro; Jose R Torrealba; Daniel Burguete; Kevin Brunner; Edwin Van Amersfoort; Yolanda Ponstein; Cees Van Kooten; Ewa Jankowska-Gan; William Burlingham; Jeremy Sullivan; Arjang Djamali; Myron Pozniak; Yucel Yankol; Luis A Fernandez Journal: Am J Transplant Date: 2020-02-20 Impact factor: 8.086
Authors: Rupal J Shah; Amir M Emtiazjoo; Joshua M Diamond; Patricia A Smith; David W Roe; Keith M Wille; Jonathan B Orens; Lorraine B Ware; Ann Weinacker; Vibha N Lama; Sangeeta M Bhorade; Scott M Palmer; Maria Crespo; David J Lederer; Edward Cantu; George J Eckert; Jason D Christie; David S Wilkes Journal: Am J Respir Crit Care Med Date: 2014-06-15 Impact factor: 21.405
Authors: H Raedler; M B Vieyra; S Leisman; P Lakhani; W Kwan; M Yang; K Johnson; S J Faas; P Tamburini; P S Heeger Journal: Am J Transplant Date: 2011-06-10 Impact factor: 8.086
Authors: Brady J Summers; Brandon L Garcia; Jordan L Woehl; Kasra X Ramyar; Xiaolan Yao; Brian V Geisbrecht Journal: Mol Immunol Date: 2015-06-04 Impact factor: 4.407
Authors: Minzhong Yu; Weilin Zou; Neal S Peachey; Thomas M McIntyre; Jinbo Liu Journal: Invest Ophthalmol Vis Sci Date: 2012-11-19 Impact factor: 4.799